Is biology destiny? Is it all in our genes?

J Psychiatr Pract

Harvard Medical School, Boston, MA 02115-6019, USA.

Published: November 2002

The completion of the working draft of the human genome in 2001 is an important milestone in achieving greater understanding of the role of genetics in health and disease. This very important technological achievement holds both promise and peril for the theory and practice of medicine. The author discusses how the information in the genome, coupled with insights into the interactions of gene and environment, may revolutionize clinical practice and eventually make it possible to tailor diagnosis and treatment to the allelic and experiential nature of the individual patient. He also points out the dangers of leaping from gene discovery to premature diagnosis and unproven interventions that may endanger patients and gives several examples of such occurrences. What is known about the relationship between gene and phenotype is reviewed and examples of the different phenotypes that may arise with identical genomes are presented to illustrate how environment influences gene expression, both in humans and other species. Finally, the author considers the challenge in conveying newly gained knowledge of genetic risk in ways that will benefit rather than harm patients.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00131746-200211000-00003DOI Listing

Publication Analysis

Top Keywords

biology destiny?
4
destiny? genes?
4
genes? completion
4
completion working
4
working draft
4
draft human
4
human genome
4
genome 2001
4
2001 milestone
4
milestone achieving
4

Similar Publications

Understanding cell destiny requires unraveling the intricate mechanism of gene regulation, where transcription factors (TFs) play a pivotal role. However, the actual contribution of TFs, that is TF activity, is not only determined by TF expression, but also accessibility of corresponding chromatin regions. Therefore, we introduce BIOTIC, an advanced Bayesian model with a well-established gene regulation structure that harnesses the power of single-cell multi-omics data to model the gene expression process under the control of regulatory elements, thereby defining the regulatory activity of TFs with variational inference.

View Article and Find Full Text PDF

Pooled clinical trial analyses evaluating outcomes of HER2-low vs HER2-0 expression in patients with metastatic breast cancer following chemotherapy.

Breast Cancer Res Treat

December 2024

Medidata AI, Medidata Solutions, a Dassault Systèmes Company, 350 Hudson Street, New York, NY, 10014, USA.

The therapeutic importance of subsetting patients with HER2-negative breast cancer according to their tumors' cellular HER2 expression (e.g., HER2-low vs.

View Article and Find Full Text PDF

Reporter Gene Assays to Measure FOXO-Specific Transcriptional Activity.

Methods Mol Biol

November 2024

Sols-Morreale Biomedical Research Institute (IIBM), Spanish National Research Council (CSIC), Universidad Autónoma de Madrid (UAM), Madrid, Spain.

The forkhead box O (FOXO) family of transcription factors translates environmental cues into precise gene expression patterns maintaining cellular equilibrium while influencing critical determinations of cell destiny and differentiation. FOXO proteins exert their effects through specific consensus binding to promoter sites within target genes. Notably, among the array of techniques available for assessing the transcriptional activity of FOXO factors, the utilization of luciferase-based reporters emerges as particularly distinctive.

View Article and Find Full Text PDF

Is biology destiny? The coherence of children's beliefs about physical and psychological traits.

J Exp Child Psychol

January 2025

Department of Psychological and Brain Sciences, Boston University, Boston, MA 02215, USA.

In adults, biological causes are commonly associated with immutability. However, it remains unclear when during their development children coherently connect these ideas in relation to reasoning about physical and mental traits and whether children reason differently by domain. Understanding this is relevant to illuminating children's conceptions about the body versus the mind.

View Article and Find Full Text PDF

As the first member of the solute carrier 6 (SLC6) protein family, the γ-aminobutyric acid (GABA) transporter 1 (GAT1, ), plays a pivotal role in the uptake of GABA from the synaptic cleft into neurons and astrocytes. This process facilitates the subsequent storage of GABA in presynaptic vesicles. The human gene is highly susceptible to missense mutations, leading to severe clinical outcomes, such as epilepsy, in the afflicted patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!